The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Huppert, J. D.
* Articles by Woods, S. W.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Huppert, J. D.
* Articles by Woods, S. W.
Related Collections
* Obsessive-Compulsive Disorder
* Panic Disorder
* Phobic Disorders
* Other Research Techniques
Am J Psychiatry 161:1485-1487, August 2004
© 2004 American Psychiatric Association


Brief Report

Differential Response to Placebo Among Patients With Social Phobia, Panic Disorder, and Obsessive-Compulsive Disorder

Jonathan D. Huppert, Ph.D., Luke T. Schultz, B.A., Edna B. Foa, Ph.D., David H. Barlow, Ph.D., Jonathan R.T. Davidson, M.D., Jack M. Gorman, M.D., M. Katherine Shear, M.D., H. Blair Simpson, M.D., Ph.D., and Scott W. Woods, M.D.

OBJECTIVE: Placebo effects in treatment of three anxiety disorders were compared. METHOD: Treatment response and patients’ treatment expectancy were examined by using data from 70 patients with obsessive-compulsive disorder, social phobia, or panic disorder who received placebo in three randomized, controlled trials comparing cognitive behavior therapy, medication, and their combination to placebo. RESULTS: Patients with obsessive-compulsive disorder were less likely to respond to placebo than patients with generalized social phobia or panic disorder. Differential expectancy did not account for these findings. CONCLUSIONS: Further examination of the placebo effect across the anxiety disorders may elucidate maintenance mechanisms of these disorders and have implications for development of more effective treatments.




This article has been cited by other articles:


Home page
J Atten DisordHome page
A.-C. Bedard and R. Tannock
Anxiety, Methylphenidate Response, and Working Memory in Children With ADHD
J Atten Disord, March 1, 2008; 11(5): 546 - 557.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
D. S. Baldwin, I. M. Anderson, D. J. Nutt, B. Bandelow, A. Bond, J. R. T. Davidson, J. A. den Boer, N. A. Fineberg, M. Knapp, J. Scott, et al.
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
J Psychopharmacol, November 1, 2005; 19(6): 567 - 596.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org